Safety profile of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: long-term interim results from the ENDORSE extension study

被引：0
|
作者：
Pozzilli, C. [1 ]
Phillips, J. T. [2 ]
Fox, R. J. [3 ]
Selmaj, K. [4 ]
Zhang, R. [5 ]
Novas, M. [5 ]
Sweetser, M. T. [5 ]
Viglietta, V. [5 ]
Gold, R. [6 ]
机构：
[1] Univ Roma La Sapienza, Dept Neurol & Psychiat, Fac Med, I-00185 Rome, Italy
[2] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Med Univ Lodz, Dept Neurol, Lodz, Poland
[5] Biogen Idec Inc, Cambridge, MA USA
[6] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany
来源：
JOURNAL OF NEUROLOGY | 2014年 / 261卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PP4153
引用
收藏
页码：S439 / S439
页数：1
相关论文
共 50 条
  • [21] Association between no evidence of disease activity (NEDA) and long-term clinical efficacy of delayed-release dimethyl fumarate (DMF) in patients with relapsing-remitting multiple sclerosis from the phase 3 study, ENDORSE
    Havrdova, E.
    Gold, R.
    Fox, R. J.
    Giovannoni, G.
    Xiao, J.
    Edwards, M. R.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 256 - 257
  • [22] The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada
    Su, Wenqing
    Kansal, Anuraag
    Vicente, Colin
    Deniz, Baris
    Sarda, Sujata
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (07) : 718 - 727
  • [23] Effect of aspirin on flushing in relapsing-remitting multiple sclerosis patients receiving delayed-release dimethyl fumarate
    Rog, D.
    Cader, S.
    Harrower, T.
    McGuigan, C.
    Young, C.
    Potts, J.
    Hanna, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 656 - 657
  • [24] Interim Results of an Open-Label Study to Assess the Effects of Delayed-release Dimethyl Fumarate on Lymphocyte Subsets and Immunoglobulins in Patients with Relapsing-remitting Multiple Sclerosis
    Von Hehn, Christian
    Mehta, Devangi
    Prada, Claudia
    Yang, Lili
    Liu, Shifang
    Ray, Soma
    Sheikh, Sarah
    NEUROLOGY, 2017, 88
  • [25] Overall Safety and Efficacy Through 10 Years of Treatment with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Bar-Or, Amit
    Fox, Robert J.
    Chen, Chongshu
    Parks, Becky
    Kapadia, Shivani
    NEUROLOGY, 2020, 94 (15)
  • [26] Overall safety and efficacy through 10 years of treatment with delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Bar-Or, A.
    Fox, R. J.
    Chen, C.
    Miller, C.
    Branco, F.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 772 - 773
  • [27] Absolute lymphocyte count and lymphocyte subset profiles during long-term treatment with delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    Fox, Robert J.
    Chan, Andrew
    Gold, Ralf
    Phillips, J. Theodore
    Selmaj, Krzysztof
    Zhang, Ray
    Chang, Ih
    Prada, Claudia
    Ray, Soma
    Mehta, Devangi
    Taylor, Catherine
    Marantz, Jing
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 155 - 155
  • [28] Absolute lymphocyte count and lymphocyte subset profiles during long-term treatment with delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    Fox, R. J.
    Chan, A.
    Gold, R.
    Phillips, J. T.
    Selmaj, K.
    Zhang, R.
    Chang, I.
    Prada, C.
    Ray, S.
    Mehta, D.
    Taylor, C.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 349 - 349
  • [29] Five-year follow-up of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: MRI outcomes from DEFINE, CONFIRM, and ENDORSE
    Yousry, T.
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    MacManus, D.
    Sheikh, S.
    Zhang, R.
    Yang, M.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 156 - 156
  • [30] Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials
    Viglietta, Vissia
    Miller, David
    Bar-Or, Amit
    Phillips, J. Theodore
    Arnold, Douglas L.
    Selmaj, Krzysztof
    Kita, Mariko
    Hutchinson, Michael
    Yang, Minhua
    Zhang, Ray
    Dawson, Katherine T.
    Sheikh, Sarah I.
    Fox, Robert J.
    Gold, Ralf
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2015, 2 (02): : 103 - 118
12345